ID29586A - ((aminoiminometil)amino) alkanakarboksamida-((aminoiminometil)amino) alkanakarboksamida dan aplikasi-aplikasinya dalam terapi - Google Patents

((aminoiminometil)amino) alkanakarboksamida-((aminoiminometil)amino) alkanakarboksamida dan aplikasi-aplikasinya dalam terapi

Info

Publication number
ID29586A
ID29586A IDW00200101657A ID20011657A ID29586A ID 29586 A ID29586 A ID 29586A ID W00200101657 A IDW00200101657 A ID W00200101657A ID 20011657 A ID20011657 A ID 20011657A ID 29586 A ID29586 A ID 29586A
Authority
ID
Indonesia
Prior art keywords
aminoiminometyl
alkanakarboksamida
amino
therapy
applications
Prior art date
Application number
IDW00200101657A
Other languages
English (en)
Inventor
Gerard Moinet
Daniel Cravo
Didier Mesangeau
Liliane Doare
Micheline Kergoat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID29586A publication Critical patent/ID29586A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
IDW00200101657A 1999-01-11 1999-12-30 ((aminoiminometil)amino) alkanakarboksamida-((aminoiminometil)amino) alkanakarboksamida dan aplikasi-aplikasinya dalam terapi ID29586A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900194A FR2788275B1 (fr) 1999-01-11 1999-01-11 ((aminoiminomethyl)amino) alcane carboxamides et leurs applications en therapeutique

Publications (1)

Publication Number Publication Date
ID29586A true ID29586A (id) 2001-09-06

Family

ID=9540749

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101657A ID29586A (id) 1999-01-11 1999-12-30 ((aminoiminometil)amino) alkanakarboksamida-((aminoiminometil)amino) alkanakarboksamida dan aplikasi-aplikasinya dalam terapi

Country Status (27)

Country Link
US (1) US6518458B1 (id)
EP (1) EP1140803B1 (id)
JP (1) JP4567889B2 (id)
KR (1) KR100630291B1 (id)
CN (1) CN1182109C (id)
AR (1) AR022221A1 (id)
AT (1) ATE252553T1 (id)
AU (1) AU760147B2 (id)
BR (1) BR9916858A (id)
CA (1) CA2359454C (id)
CZ (1) CZ20012482A3 (id)
DE (1) DE69912315T2 (id)
DK (1) DK1140803T3 (id)
EE (1) EE200100363A (id)
ES (1) ES2207325T3 (id)
FR (1) FR2788275B1 (id)
HK (1) HK1041689B (id)
HU (1) HUP0200023A3 (id)
ID (1) ID29586A (id)
IL (1) IL144225A0 (id)
NO (1) NO20013420L (id)
NZ (1) NZ513467A (id)
PT (1) PT1140803E (id)
RU (1) RU2236401C2 (id)
SK (1) SK285130B6 (id)
WO (1) WO2000042001A1 (id)
ZA (1) ZA200106606B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1771206T1 (en) * 2004-05-05 2018-06-29 Silence Therapeutics Gmbh Lipids, lipid complexes and use thereof
CN101287497B (zh) 2004-12-27 2013-03-06 赛伦斯治疗公司 涂层脂质复合体和它们的用途
TW200808705A (en) * 2006-06-15 2008-02-16 Sanofi Aventis Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
AU2007276388A1 (en) * 2006-07-21 2008-01-24 Silence Therapeutics Ag Means for inhibiting the expression of protein kinase 3
WO2010074591A1 (ru) * 2008-12-24 2010-07-01 Закрытое Акционерное Общество "Beptekc" Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153424A (en) * 1965-04-15 1969-05-29 Horlicks Ltd Pharmaceutical Compositions
US5654451B1 (en) * 1993-01-14 2000-02-22 Magainin Pharma Amino acids and peptides having modified c-terminals and modified n-terminals
JPH0841008A (ja) * 1994-07-29 1996-02-13 Ono Pharmaceut Co Ltd 一酸化窒素合成酵素阻害剤
CA2217550A1 (en) * 1996-10-22 1998-04-22 F. Hoffmann-La Roche Ag Cationic lipids for gene therapy
RU2125458C1 (ru) * 1997-04-02 1999-01-27 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия Способ получения комплекса, обладающего адаптогенным, гипогликемическим, антигипоксическим и противовоспалительным действием
US6395713B1 (en) * 1997-07-23 2002-05-28 Ribozyme Pharmaceuticals, Inc. Compositions for the delivery of negatively charged molecules
DE19748697A1 (de) * 1997-11-04 1999-05-06 Basf Ag Verfahren zur Herstellung von substituierten Guanidinderivaten

Also Published As

Publication number Publication date
ES2207325T3 (es) 2004-05-16
CN1333747A (zh) 2002-01-30
US6518458B1 (en) 2003-02-11
NO20013420D0 (no) 2001-07-10
PT1140803E (pt) 2004-03-31
JP4567889B2 (ja) 2010-10-20
CZ20012482A3 (cs) 2001-10-17
AU760147B2 (en) 2003-05-08
HK1041689A1 (en) 2002-07-19
HK1041689B (zh) 2005-09-02
AU3044300A (en) 2000-08-01
EP1140803B1 (en) 2003-10-22
HUP0200023A3 (en) 2003-04-28
HUP0200023A2 (hu) 2002-05-29
CA2359454A1 (en) 2000-07-20
CN1182109C (zh) 2004-12-29
ATE252553T1 (de) 2003-11-15
KR100630291B1 (ko) 2006-09-29
AR022221A1 (es) 2002-09-04
KR20010089822A (ko) 2001-10-08
ZA200106606B (en) 2002-11-11
BR9916858A (pt) 2001-12-04
DK1140803T3 (da) 2003-12-22
SK9842001A3 (en) 2001-12-03
NO20013420L (no) 2001-07-10
FR2788275B1 (fr) 2002-06-14
EP1140803A1 (en) 2001-10-10
NZ513467A (en) 2003-08-29
WO2000042001A1 (en) 2000-07-20
JP2002534496A (ja) 2002-10-15
EE200100363A (et) 2002-10-15
DE69912315T2 (de) 2004-08-05
CA2359454C (en) 2009-10-27
SK285130B6 (sk) 2006-07-07
IL144225A0 (en) 2002-05-23
FR2788275A1 (fr) 2000-07-13
RU2236401C2 (ru) 2004-09-20
DE69912315D1 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
EE05210B1 (et) Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
DE69801976D1 (de) Zusammensetzung und Gegenstand mit verbessertem Druckverformungsrest
ID26599A (id) Turunan triazola dan imidazola
PL352186A1 (en) Running and testing applications
DE69728434D1 (de) Ankoppelvorrichtung und flaschen
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
DE59812245D1 (de) Pump- und dosiervorrichtung
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE60021260D1 (de) Wassergetragene vulkanisierbare fluorgummimischungen und damit beschichteter gegenstand
ID24196A (id) Komposisi dan penggunaan
ID23159A (id) Wafer dan pembuatannya
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
HUP0500995A3 (en) Casein derived peptides and uses thereof in therapy
IL128570A0 (en) Protein kinases and uses thereof
ID29586A (id) ((aminoiminometil)amino) alkanakarboksamida-((aminoiminometil)amino) alkanakarboksamida dan aplikasi-aplikasinya dalam terapi
ID27479A (id) Turunan piridina dan sediaan farmasinya
DE69816241D1 (de) Aktivierte peptide und konjugate
EE9900555A (et) Mobiilses transiiveris kasutatav meetod ja seade
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
IL153740A0 (en) Grf2-binding proteins and applications thereof
SI1140803T1 (en) ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
DE59812220D1 (de) Halte- und trageband
IDP000021741A (id) Turunan-turunan n-(4-aril-tiazol-2-il)-sulfonamida dan pemakaiannya